REPRESENTING VICTIMS OF CATASTROPHIC PERSONAL
INJURY & WRONGFUL DEATH |
CONTACT US TODAY
FOR A FREE CASE EVALUATION
 Have
a personal injury case?
Get a FREE assessment. |
Texas Prescription Drug Litigation Lawyer | Dallas, Houston, Fort Worth,
(DFW) | Texas Prescription Drug Litigation Attorney | Dallas, Houston, Fort
Worth, (DFW)
AREAS OF PRACTICE
DRUG LITIGATION
We are currently investigating injuries related to the recall of Bard Composix Kugel Mesh Patches that are used in the repair of hernias. The recalled patches were manufactured from 2001 through March, 2006 and include only the large and extra large patches.
The patches are held open by a "memory recoil ring" that allow the patch to be folded for insertion through a small incision and later sprung open to lay flat once it is in place. Unfortunately, the stress of placing the large-sized patches (4.5 inches in diameter and larger) in the intra-abdominal space can cause the ring to break, leading to serious and life-threatening injuries.
Injuries can include: persistent surgical site drainage, bowel paralysis, persistent abdominal pain, abdominal tenderness, distended abdomen, fever, fluid in the abdomen, abdominal abscess, intestinal or bowel perforation, intestinal fistulas, external fistulas, pelvic inflammatory disease, sepsis, peritonitis, or corrective surgery.
Learn more about the dangers of the Kugel Mesh Patch at www.kugelmeshlawfirm.com
On January 20, 2006, researchers reported three cases of severe liver problems, including one death, in patients at a North Carolina hospital after they began taking the antibiotic Ketek (Generic: Telithromycin). Federal regulators said they are examining an unknown number of U.S. cases involving Ketek and are consulting with overseas counterparts.
Ketek, manufactured by Sanofi-Aventis, was approved in 2004 for the treatment of acute bacterial infections from chronic bronchitis, acute bacterial sinusitis and community-acquired pneumonia. An FDA spokeswoman said that the agency would examine its databases for other reports of liver problems in patients taking Ketek.
Learn more about the dangers of Ketek at www.theketeklaw.com
(c) Merck & Co. withdrew its arthritis drug Vioxx from sales worldwide Thursday because an ongoing trial confirmed the medication increases the risk of heart attack and strokes.
The Whitehouse Station, N.J.- based drugmaker said the immediate withdrawal was based on data from a three-year colon cancer clinical trial that showed a heightened risk of cardiovascular complications began 18 months after patients started taking Vioxx rather than dummy pills.
People who are currently taking Vioxx should consult their healthcare provider about the ongoing treatment using Vioxx and should also obtain information on alternative treatments.
Learn more about the dangers and side effects of Vioxx at www.thevioxxlaw.com
Fosamax (Generic: Alendronate), manufactured by Merck, gained FDA approval in 1995. Fosamax is prescribed to treat osteoporosis and Paget's disease. Fosamax is a type of drug known as bisphosphonates. Individuals using Fosamax or other bisphosphonates should attempt to steer clear of tooth extractions and other major dental work while on the drugs.
A connection between Fosamax and other bisphosphonates and a serious bone disease called Osteonecrosis of the Jaw (ONJ) was found. Osteonecrosis of the Jaw (ONJ) is also known as Dead Jaw. This finding was published in the Journal of Oral and Maxillofacial Surgeons, and it prompted the US Food and Drug Administration (FDA) and the manufacturer of Fosamax to issue a warning to health care professionals on September 24, 2004.
Learn more about the dangers and side effects of Fosamax at www.thefosamaxlaw.com
In today's world many of the very drugs that are supposed to improve the quality of our lives have been discovered to have devastating side effects. Drugs including Fen-Phen, Baycol, Rezulin and over-the-counter products containing PPA have been found to cause life-threatening complications. Our firm stands ready to assist you or your family in pursuing cases against drug or medical device manufacturers that have failed to properly test their products or include appropriate warnings. If you have questions regarding any serious injury or death that you believe related to a drug or medical device, please contact our office.
(a) PPA Cases: Phenylpropanolamine (PPA) was an additive to numerous cough and cold medications, along with many different diet drugs. For several decades, the medical community has reported problems caused by PPA, principally involving hemorrhagic or bleeding strokes. In November of 2000, the FDA demanded that all products containing PPA be removed from the market. We have reviewed more than 200 potential PPA cases, and are currently in litigation with many different clients who suffered from hemorrhagic strokes caused by a PPA containing product.
(b)
Prempro and Premarin are the two major HRT drugs. Both are manufactured by Wyeth Pharmaceuticals. Prempro is a combination estrogen-progestin treatment and Premarin is an estrogen-only treatment. There are approximately 6 million women taking Prempro and 11 million women taking Premarin. Last year, the two drugs had combined sales of $2.1 billion dollars.
As Prempro and Premarin are the two major existing HRT drugs; However, other drugs and treatments may have the same harmful effects and you should consult a physician if you believe the treatment you are on may be harmful to your health.
Learn more about the dangers of Prempro at www.thepremprolaw.com
|
